NCT03117699

Brief Summary

This is a study for a new mechanical transport device adapted to the hemiplegic patients. Healthy volunteers : After explaining the protocol and presenting the movement laboratory, the subjects are equipped with reflective markers on the 4 limbs, the trunk and the head. The subjects are installed on a seat positioned in front of 2 force platforms installed on the ground. The seat is equipped with a force platform. Phase 1 : After being seated, the subject realizes :

  • 3 seat to stand and stand to seat without assistance
  • 3 seat to stand and stand to seat using a handle located in front of it (handle equipped with a 6-axis force sensor)
  • 3 seat to stand and stand to seat using the experimental device This phase will last 45minutes (mn) (30mn of equipment and 15mn of sitting passengers standing) Phase 2: After being seated, the subject performs a course comprising:
  • A standing pass from sitting on a chair
  • A straight line movement
  • A succession of left and right turns
  • An upward and downward travel of less than 1%.
  • Standard doorway
  • Standing on the toilet
  • A sitting pass from the toilet
  • One way to a bed
  • A sitting pass on the bed
  • A passenger seat sitting upright from the bed
  • A return to the starting point
  • A sitting pass on the starting chair Each stage is timed. A subjective analysis of each step is done by a lickert scale on the perceived comfort and safety. This phase 2 will last 30mn (15mn of course and 15mn of questions). Hemiplegic subjects : At each session, the subject is examined by a physician who evaluates the motor control (Fugl Meyer scale), the equilibrium (Berg scale) and the spatial hemineglect (Bergego scale). Phase 1 is performed except the 3 seat to stand and stand to seat without assistance which are impossible. Phase 2 is performed. An evaluation of the device over 4 hours is carried out for each subject in therapeutic apartment in simulated living conditions. The validation in living lab is carried out by an ergonomist and by a questionnaire on the comfort and safety of the various steps identified by the ergonomist.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2017

Completed
15 days until next milestone

Study Start

First participant enrolled

April 13, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 18, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 13, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 13, 2018

Completed
Last Updated

March 4, 2022

Status Verified

March 1, 2022

Enrollment Period

1 year

First QC Date

March 29, 2017

Last Update Submit

March 3, 2022

Conditions

Keywords

Hemiplegiatransport device

Outcome Measures

Primary Outcomes (1)

  • Time required to carry out each step of use of the device

    Each step of phase 1 and phase 2 will be timed.

    Day 1

Secondary Outcomes (1)

  • Record of all adverse reactions.

    Day 1

Study Arms (2)

Hemiplegic subjects

EXPERIMENTAL

Testing of a new device for seated-standing passages after undergoing medical evaluation included Fugl Meyer scale, Berg scale and Bergego scale. Phase 1 : * 3 seated-standing passages with a handle equipped with 6 force captors * 3 seated-standing passages with the device

Device: New device for seated-standing passages

Healthy volunteers

EXPERIMENTAL

Testing of a new device for seated-standing passages . Phase 1 : * 3 seated-standing passages without help * 3 seated-standing passages with a handle equipped with 6 force captors * 3 seated-standing passages with the device

Device: New device for seated-standing passages

Interventions

Phase 1 : The subject perform different seated-standing passages (see "Arm") Phase 2 : After being seated, the subject performs a course comprising: * A standing pass from sitting on a chair * A straight line movement * A succession of left and right turns * An upward and downward travel of less than 1%. * Standard doorway * Standing on the toilet * A sitting pass from the toilet * One way to a bed * A sitting pass on the bed * A passenger seat sitting upright from the bed * A return to the starting point * A sitting pass on the starting chair

Healthy volunteersHemiplegic subjects

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers :
  • aged 18-75 years
  • Subject having given his consent
  • Free from any neurological or cardiorespiratory locomotor pathology that may interfere with standing seated passages.
  • Hemiplegic patients :
  • Left hemiplegia in one of the following groups :
  • Walking with difficulty or not walking and able to stand with a stick or an armrest
  • Walking difficult or not walking and unable to stand with a cane or an armrest.
  • aged 18-90 years
  • Subject having given his consent
  • Subjects with a trunk balance to sit without support

You may not qualify if:

  • aged less than 18 or more than 75 (healthy volunteers) or more than 90 (hemiplegic subjects)
  • Pain during seated-standing passages
  • Unstable medical condition
  • Unable to consent
  • Subject under legal protection
  • Left-hemineglect making standing or seated (wheelchair) displacements impossible autonomously (for hemiplegic patients)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Brest University Hospital

Brest, 29200, France

Location

Centre de rééducation fonctionnelle de KERPAPE

Ploemeur, 56000, France

Location

MeSH Terms

Conditions

Hemiplegia

Condition Hierarchy (Ancestors)

ParalysisNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2017

First Posted

April 18, 2017

Study Start

April 13, 2017

Primary Completion

April 13, 2018

Study Completion

April 13, 2018

Last Updated

March 4, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations